Peri-aortic fat tissue thickness in peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 33, Issue 3, 2013, Pages 316-324

  Turkmen, Kultigin ^a   Ozbek, Orhan ^a   Kayrak, Mehmet ^a   Samur, Cigdem ^a   Guler, Ibrahim ^a   Tonbul, Halil Zeki ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Coronary artery calcification; Epicardial adipose tissue; Peri aortic fat tissue; Thoracic aortic calcification

Indexed keywords

ADIPOSE TISSUE; ADULT; AGE; AGED; ARTERY CALCIFICATION; ARTICLE; CARDIAC GATED IMAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; EPICARDIUM ADIPOSE TISSUE; FEMALE; HUMAN; HYPERTENSION; LINEAR REGRESSION ANALYSIS; MALE; MAMMARY ARTERY; MEASUREMENT; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATIENT; PERI AORTIC FAT TISSUE; PERITONEAL DIALYSIS PATIENT; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; THICKNESS; TREATMENT DURATION;

CORONARY ARTERY CALCIFICATION; EPICARDIAL ADIPOSE TISSUE; PERI-AORTIC FAT TISSUE; THORACIC AORTIC CALCIFICATION;

AGED; AORTA, THORACIC; CALCINOSIS; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INTRA-ABDOMINAL FAT; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PERICARDIUM; PERITONEAL DIALYSIS; PREDICTIVE VALUE OF TESTS;

EID: 84878957071     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2011.00165     Document Type: Article

References (42)

1. Kremen J, Dolinkova M, Krajickova J, Blaha J, Anderlova K, Lacinova Z, et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 2006; 91:4620-7.
2. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barré PE. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 1996; 49:1428-34.
3. Collins AJ. Cardiovascular mortality in end-stage renal disease. Am J Med Sci 2003; 325:163-7.
4. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barré PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11:1277-85.
5. Després JP, Ferland M, Moorjani S, Nadeau A, Tremblay A, Lupien PJ, et al. Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis 1989; 9:485-92.
6. van der Kooy K, Leenen R, Seidell JC, Deurenberg P, Visser M. Abdominal diameters as indicators of visceral fat: comparison between magnetic resonance imaging and anthropometry. Br J Nutr 1993; 70:47-58.
7. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005; 2:536-43.
8. Corradi D, Maestri R, Callegari S, Pastori P, Goldoni M, Luong TV, et al. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc Pathol 2004; 13:313-16.
9. Shirani J, Berezowski K, Roberts WC. Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. Am J Cardiol 1995; 76:414-18.
10. Djaberi R, Schuijf JD, van Werkhoven JM, Nucifora G, Jukema JW, Bax JJ. Relation of epicardial adipose tissue to coronary atherosclerosis. Am J Cardiol 2008; 102:1602-7.
11. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108:2460-6.
12. Park MJ, Jung JI, Oh YS, Youn HJ. Assessment of epicardial fat volume with threshold-based 3-dimensional segmentation in CT: comparison with the 2-dimensional short axis-based method. Korean Circ J 2010; 40:328-33.
13. Eroglu S, Sade LE, Yildirir A, Bal U, Ozbicer S, Ozgul AS, et al. Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis 2009; 19:211-17.
14. Yorgun H, Canpolat U, Hazirolan T, Sunman H, Ates AH, Gürses KM, et al. Epicardial adipose tissue thickness predicts descending thoracic aorta atherosclerosis shown by multidetector computed tomography. Int J Cardiovasc Imaging 2011;: [Epub ahead of print].
15. Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G, et al. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res 2009; 104:541-9.
16. Yudkin JS, Eringa E, Stehouwer CD. "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005; 365:1817-20.
17. Fantuzzi G, Mazzone T. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol 2007; 27:996-1003.
18. Fox CS, Massaro JM, Schlett CL, Lehman SJ, Meigs JB, O'Donnell CJ, et al. Periaortic fat deposition is associated with peripheral arterial disease: the Framingham heart study. Circ Cardiovasc Imaging 2010; 3:515-19.
19. Lehman SJ, Massaro JM, Schlett CL, O'Donnell CJ, Hoffmann U, Fox CS. Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Atherosclerosis 2010; 210:656-61.
20. Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, Wolf PA, et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 2009; 30:850-6.
21. Schlett CL, Massaro JM, Lehman SJ, Bamberg F, O'Donnell CJ, Fox CS, et al. Novel measurements of periaortic adipose tissue in comparison to anthropometric measures of obesity, and abdominal adipose tissue. Int J Obes (Lond) 2009; 33:226-32.
22. Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008; 117:605-13.
23. Turkmen K, Kayikcioglu H, Ozbek O, Solak Y, Kayrak M, Samur C, et al. The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis/calcification syndrome in ESRD patients. Clin J Am Soc Nephrol 2011; 6:1920-5.
24. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, et al. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-47.
25. Abbara S, Desai JC, Cury RC, Butler J, Nieman K, Reddy V. Mapping epicardial fat with multi-detector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation. Eur J Radiol 2006; 57:417-22.
26. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15:827-32.
27. Taniguchi H, Momiyama Y, Fayad ZA, Ohmori R, Ashida K, Kihara T, et al. In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography. Am Heart J 2004; 148:137-43.
28. Khoury Z, Gottlieb S, Stern S, Keren A. Frequency and distribution of atherosclerotic plaques in the thoracic aorta as determined by transesophageal echocardiography in patients with coronary artery disease. Am J Cardiol 1997; 79:23-7.
29. Ahn SG, Lim HS, Joe DY, Kang SJ, Choi BJ, Choi SY, et al. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart 2008; 94:e7.
30. Sarin S, Wenger C, Marwaha A, Qureshi A, Go BD, Woomert CA, et al. Clinical significance of epicardial fat measured using cardiac multislice computed tomography. Am J Cardiol 2008; 102:767-71.
31. Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, et al. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearance, and proteinuria in patients with normal renal functions. Int Urol Nephrol 2007; 39:1227-33.
32. Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincón A, et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 2010; 5:1388-93.
33. Menè P, Punzo G. Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens 2008; 26:2085-92.
34. Fortes PC, de Moraes TP, Mendes JG, Stinghen AE, Ribeiro SC, Pecoits-Filho R. Insulin resistance and glucose homeostasis in peritoneal dialysis. Perit Dial Int 2009; 29(Suppl 2):S145-8.
35. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997; 51:182-6.
36. Ateshkadi A, Johnson CA, Founds HW, Zimmerman SW. Serum advanced glycosylation end-products in patients on hemodialysis and CAPD. Perit Dial Int 1995; 15:129-33.
37. Wu HY, Hung KY, Hu FC, Chen YM, Chu TS, Huang JW, et al. Risk factors for high dialysate glucose use in PD patients-a retrospective 5-year cohort study. Perit Dial Int 2010; 30:448-55.
38. Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 2004; 19:1489-96.
39. London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul MC. Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 2008; 19:1827-35.
40. Demirci MS, Ozkahya M, Asci G, Sevinc E, Yilmaz M, Demirci C, et al. The influence of dialysate calcium on progression of arterial stiffness in peritoneal dialysis patients. Perit Dial Int 2009; 29(Suppl 2):S15-17.
41. Mizobuchi M, Finch JL, Martin DR, Slatopolsky E. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int 2007; 72:709-15.
42. Wang AY. Vascular and valvular calcification in chronic peritoneal dialysis patients. Int J Nephrol 2011; 2011:198045.